Does chlorhexidine bathing in adult intensive care units reduce blood culture contamination? A pragmatic cluster-randomized trial

Infection Control and Hospital Epidemiology

Volumn 35, Issue , 2014, Pages S17-S22

  Septimus, Edward J ^a,b   Hayden, Mary K ^c   Kleinman, Ken ^d   Avery, Taliser R ^d   Moody, Julia ^a   Weinstein, Robert A ^e   Hickok, Jason ^a   Lankiewicz, Julie ^d   Gombosev, Adrijana ^f   Haffenreffer, Katherine ^d   Kaganov, Rebecca E ^d   Jernigan, John A ^g   Perlin, Jonathan B ^a   Platt, Richard ^d   Huang, Susan S ^f  

^a HOSPITAL CORPORATION OF AMERICA   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d HARVARD UNIVERSITY   (United States)

^e Cook County Health and Hospitals System ^*  (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE; PSEUDOMONIC ACID; DISINFECTANT AGENT;

ADULT; AGED; ARTICLE; BACILLUS; BACTERIAL COLONIZATION; BACTERIUM CONTAMINATION; BATH; BLOOD CULTURE; CONTROLLED STUDY; FEMALE; HUMAN; INTENSIVE CARE UNIT; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PARASITE ISOLATION; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCUS; STREPTOCOCCUS; CROSS INFECTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; MIDDLE AGED; NOSE CAVITY; PROCEDURES; SEPSIS; STAPHYLOCOCCAL INFECTIONS; STATISTICS AND NUMERICAL DATA;

AGED; BATHS; CHLORHEXIDINE; CROSS INFECTION; DISINFECTANTS; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; NASAL CAVITY; SEPSIS; STAPHYLOCOCCAL INFECTIONS;

EID: 84907990000     PISSN: 0899823X     EISSN: 15596834     Source Type: Journal    
DOI: 10.1086/677822     Document Type: Article

References (20)

1. Weinbaum FI, Lavie S, Danek M, Sixsmith D, Heinrich GF, Mill SS. Doing it right the first time: quality improvement and the contaminant blood culture. J Clin Microbiol 1997;35(3):563–565.
2. Weinstein MP. Blood culture contamination: persisting problems and partial progress. J Clin Microbiol 2003;41:2275–2278.
3. Clinical and Laboratory Standards Institute (CLSI). Principles and Procedures for Blood Cultures: Approved Guideline. Wayne, PA: CLSI; 2007. CLSI document M47-A.
4. Hall KK, Lyman JA. Updated review of blood culture contamination. Clin Microbiol Rev 2006;19(4):788–802.
5. Bekeris LG, Tworek JA, Walsh MK, et al. Trends in blood culture contamination: a College of American Pathologists Q-Tracks study of 356 institutions. Arch Pathol Lab Med 2005;129:1222–1225.
6. Stohl S, Benenson S, Sviri S, et al. Blood culture at central line insertion in the intensive care unit: comparison with peripheral venipuncture. J Clin Microbiol 2011;49:2398–2403.
7. Darby JM, Linden P, Pasculle W, Saul M. Utilization and diagnostic yield of blood cultures in a surgical intensive care unit. Crit Care Med 1997;25:989–994.
8. Bates DW, Goldman L, Lee TH. Contaminant blood cultures and resource utilization: the true consequences of false-positive results. JAMA 1991;265:365–369.
9. Pien BC, Sundaram P, Raoof N, et al. The clinical and prognostic importance of positive blood cultures in adults. Am J Med 2010; 123(9):819–828.
10. Souvenir D, Anderson DE Jr, Palpant S, et al. Blood cultures positive for coagulase-negative staphylococci: antisepsis, pseudobacteremia, and therapy of patients. J Clin Microbiol 1998;36: 1923–1926.
11. Gander RM, Byrd L, DeCrescenzo M, et al. Impact of blood cultures drawn by phlebotomy on contamination rates and health care costs in a hospital emergency department. J Clin Microbiol 2009;47:1021–1024.
12. Alahmadi YM, Aldeyab MA, McElnay JC, et al. Clinical and economic impact of contaminated blood cultures within the hospital setting. J Hosp Infect 2011;77(3):233–236.
13. Viagappan M, Kelsey MC. The origin of coagulase-negative staphylococci isolated from blood cultures. J Hosp Infect 1995; 30:217–223.
14. Mylotte JM, Tayara A. Blood cultures: clinical aspects and controversies. Eur J Clin Microbiol Infect 2000;19:157–163.
15. Washer LL, Chenoweth C, Kim H-W, et al. Blood culture contamination: a randomized trial evaluating the comparative effectiveness of 3 skin antiseptic interventions. Infect Control Hosp Epidemiol 2013;34:15–21.
16. Bleasdale SC, Trick WE, Gonzalez IM, et al. Effectiveness of chlorhexidene bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. Arch Intern Med 2007;167:2073–2079.
17. Popovich KJ, Hota B, Hayes BA, et al. Effectiveness of routine patient cleansing with chlorhexidene gluconate for infection prevention in the medical intensive care unit. Infect Control Hosp Epidemiol 2009;30:959–963.
18. Popovich KJ, Hota B, Hayes BA, et al. Daily skin cleansing with chlorhexidene did not reduce the rate of central-line associated bloodstream infection in a surgical intensive care unit. Intensiv Care Med 2010;36:854–858.
19. Huang SS, Septimus E, Kleinman K, et al. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med 2013;368:2255–2265.
20. Popovich KJ, Lyles R, Hayes BA, et al. Relationship between chlorhexidine gluconate skin concentration and microbial density on the skin of critically ill patients bathed daily with chlorhexidine gluconate. Infect Control Hosp Epidemiol 2012;33:889–896.